The following table details the trading activities
(stock purchases, stock sales, and stock option exercises)
the Securities and Exchange Commission (SEC)
by insider Henel Rolf H since year 2005.
The trader's CIK number is 1226959.
At the time of this reporting, Henel Rolf H is the Director of Sciclone Pharmaceuticals Inc .
(stock ticker symbol SCLN).
See this page for all insider trading activities at Sciclone Pharmaceuticals Inc .
|Trade Date||Symbol||Company Name (Issuer)||Trade Type||Shares||Price ($)||Value ($)|
|2009-05-14||SCLN||Sciclone Pharmaceuticals Inc||Option Ex||10,000||1.44||14,400|
|2008-05-14||SCLN||Sciclone Pharmaceuticals Inc||Buy||5,000||1.80||9,000|
|2008-05-13||SCLN||Sciclone Pharmaceuticals Inc||Buy||34,400||1.78||61,335|
|2007-12-31||SCLN||Sciclone Pharmaceuticals Inc||Sale||9,400||2.08||19,514|
|2007-12-28||SCLN||Sciclone Pharmaceuticals Inc||Buy||9,400||2.27||21,300|
|2007-11-20||SCLN||Sciclone Pharmaceuticals Inc||Buy||100||1.81||181|
|2007-11-23||SCLN||Sciclone Pharmaceuticals Inc||Buy||500||1.85||925|
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Henel Rolf H (Director of Sciclone Pharmaceuticals Inc at the time of this reporting) see the Securities and Exchange Commission (SEC) website.